Canada — Manitoba Regulation

Canada — Manitoba legislation

Pharmaceutical (General Matters) Regulation, 2013

This regulation defines key terms, lists certain substances as drugs, excludes naloxone products in emergency opioid-overdose use from being treated as drugs, and restricts sales of Schedule 1 drugs by members.

drug schedulingsale of prescribed drugs

Professional statute overview

Enactment structure, operative effect and source provenance

Official source

01

Purpose and legislative effect

“This regulation defines key terms, lists certain substances as drugs, excludes naloxone products in emergency opioid-overdose use from being treated as drugs, and restricts sales of Schedule 1 drugs by members.”

Use this record to locate individual provisions, understand the instrument’s recorded structure, and move from a research summary to the exact source text.

02

How the instrument operates

  1. 01

    Start with the recorded version

    Enacted 2013. The date shown identifies this source expression and should not be treated as proof that no later change exists.

  2. 02

    Locate the controlling provision

    Use the provision map, part headings and full-text filter to move from the broad subject to the exact legal language.

  3. 03

    Read conditions and exceptions together

    Keep subsections, definitions, provisos and cross-references in context before drawing a legal conclusion.

  4. 04

    Verify currency and official wording

    Confirm later legislation, commencement notices and corrections with the official publisher before advice, filing or reliance.

03

Research entry points

Selected provisions across the instrument. Open any row to continue with the exact stored text.

Pharmaceutical (General Matters) Regulation

This regulation defines key terms, lists certain substances as drugs, excludes naloxone products in emergency opioid-overdose use from being treated as drugs, and restricts sales of Schedule 1 drugs by members.

Document — Pharmaceutical (General Matters) Regulation

04

Source and current-law status

Source record view

Source record from web2.gov.mb.ca · Enacted 2013

Verify current force

The source record does not state a definitive current-law status. Check the official publisher and later amendments before relying on this text.

Source-indexed provision map

Sections and provisions

Search by section, heading, part or exact legal wording. Every result remains linked to the stored source record.

Showing 1 of 1 provisions

Amendment
§ —Pharmaceutical (General Matters) RegulationAmendment

This regulation defines key terms, lists certain substances as drugs, excludes naloxone products in emergency opioid-overdose use from being treated as drugs, and restricts sales of Schedule 1 drugs by members.

Pharmaceutical (General Matters) Regulation, M.R. 194/2013 The Pharmaceutical Act , C.C.S.M. c. P60 Regulation 194/2013 Registered December 17, 2013 bilingual version (HTML) Definitions 1 The following definitions apply in this regulation. "Act" means The Pharmaceutical Act ; («  Loi  ») "Manual" means the Manual for Canada's National Drug Scheduling System published by the National Association of Pharmacy Regulatory Authorities, as amended from time to time. (« manuel ») M.R. 141/2020 Prescribed drugs 2 The following are prescribed as drugs for the purpose of the definition "drug" in subsection 1(1) of the Act: (a) the substances and mixtures of substances listed in Schedules 1, 2 and 3 of the Manual; (b) a substance or mixture of substances that contains pseudoephedrine as the single active ingredient. M.R. 141/2020 ; 25/2023 Exception — naloxone hydrochloride 2.1 Despite section 2, the following are not drugs for the purpose of the definition "drug" in subsection 1(1) of the Act: (a) naloxone hydrochloride injection, when indicated for emergency use for opioid overdose; (b) naloxone hydrochloride nasal spray, when indicated for emergency use for opioid overdose. M.R. 141/2020 Designated practitioners 3(1) Subject to subsection (2), the following persons are designated as practitioners for the purpose of the definition "practitioner" in subsection 1(1) of the Act: (a) a pharmacist authorized to practise pharmacy in Manitoba or another Canadian province or territory; (b) a registered nurse authorized to practise registered nursing in Manitoba or another Canadian province or territory; (c) an optometrist authorized to practise optometry in Manitoba or another Canadian province or territory; (d) a midwife authorized to practise midwifery in Manitoba or another Canadian province or territory; (e) a registered psychiatric nurse authorized to practise registered psychiatric nursing in Manitoba or another Canadian province or territory; (f) a podiatrist authorized to practise podiatry in Manitoba or another Canadian province or territory. 3(2) A person is designated under subsection (1) only to the extent that they have authority to prescribe under the enactment that authorizes them to practise. M.R. 141/2020 ; 25/2023 Limits on sale of particular drugs 4 A member must not sell a drug listed in Schedule 1 of the Manual unless (a) the drug is sold to a practitioner; or (b) the drug is dispensed pursuant to a prescription. Coming into force 5 This regulation comes into force on the day The Pharmaceutical Act , S.M. 2006, c. 37, comes into force.
Document — Pharmaceutical (General Matters) RegulationVerify source

Legislative relationships

1 referenced instrument

Names are derived from the stored provision headings and citation-enrichment layer. Treat this as a research index and verify each relationship against the source text.

N–S

1 instrument

  • Schedule 1 drugs by members. Pharmaceutical (General Matters) Regulation

    Section Document — Pharmaceutical (General Matters) Regulation

Recorded versions and source checkpoint

1 version available in this collection

Current-law checkpoint
  • Undated version · currentEnglish

Source-linked research

Ask AI about this statute

The overview, provisions, and source records above are public. Continue in a separate conversation with this statute’s jurisdiction and source version attached.

About this LexChat collection

Statute information is organised from identified legislative sources for professional research. Corrections can be reported to hello@esheria.ai.